A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma.
Mingze GuanHua ZhaoQi ZhangLi LiXiaobo WangBo TangPublished in: Expert review of molecular diagnostics (2024)
The ARG-based signature may provide a promising direction for prognosis prediction and treatment optimization for DLBCL patients.